Repurposing drug shows promise in fighting aggressive brain tumors

Glioblastoma is the most common — and the most malignant — primary brain tumour in adults. It’s aggressive and incurable. Even with treatment including surgical removal and chemotherapy, the median survival for patients is just 18 months.

Now, innovative new research led by Dr. Arezu…

Continue Reading


Posted

in

by

Tags:

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *